Insight Molecular Diagnostics Inc.

IMDX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $9.5M

Liabilities Breakdown FY2018

Total Liabilities: $6.1M